For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Joy of consulting and low-carb prescribing - Watch out for ‘pings’ says award-winning GP
Joy of consulting and low-carb prescribing - Watch out for ‘pings’ says award-winning GP

PRIMARY STARS
Medtech GP of the Year Glen Davies talks to Fiona Cassie about his low-carb mission, the consultation, and being too accessible
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Lean MEJ, Leslie WS, Barnes AC et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet 2018;391, 10120:541–51.
tinyurl.com/DirectDiabetes
2. Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743.
tinyurl.com/LowCarbBMJReview